Client News
Filter by:
- Dec 10 2020 VistaGen Announces Korean Intellectual Property Office Decision to Grant PH10 Patent for Treatment of Depression
- Dec 1 2020 VistaGen Therapeutics Expands R&D Team with Appointment of Louis Monti, M.D., Ph.D., Pioneer in the Development of Neuroactive Steroids known as Pherines as Potential Treatments for Anxiety and Depression Disorders, as Vice President, Translational Medicine
- Dec 1 2020 Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
- Dec 1 2020 Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
- Nov 24 2020 Emerald Health Therapeutics Announces Full Prepayment of Convertible Debentures
- Nov 24 2020 Emerald Health Therapeutics Announces Full Prepayment of Convertible Debentures
- Nov 20 2020 Q BioMed's Strontium89 Advertisement "Unfinished Business" Selected for Prestigious Ads of the World's Best Creative Campaigns
- Nov 16 2020 Q BioMed's Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer
- Nov 16 2020 Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.
- Nov 16 2020 Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.